InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Allogene Therapeutics, Inc.

ALLO Clue Score24
United States Fiscal year ends December CIK 0001737287 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

32
Insider
Date
Role
Action
Shares
Price
Amount
Veer Bhavnagri
15 Sep 2021
General Counsel
Sold after exercise
5,000
$24.77
$123.84K
Veer Bhavnagri
16 Aug 2021
General Counsel
Sold after exercise
5,000
$21.00
$104.99K
Veer Bhavnagri
15 Jul 2021
General Counsel
Sold after exercise
5,000
$21.55
$107.75K
Veer Bhavnagri
15 Jun 2021
General Counsel
Sold after exercise
5,000
$25.32
$126.60K
Veer Bhavnagri
18 May 2021
General Counsel
Sold after exercise
5,000
$30.00
$150.00K
Veer Bhavnagri
17 May 2021
General Counsel
Sold after exercise
5,000
$28.30
$141.48K
Veer Bhavnagri
15 Apr 2021
General Counsel
Sold after exercise
606
$32.64
$19.78K
Veer Bhavnagri
15 Apr 2021
General Counsel
Sold after exercise
9,394
$32.01
$300.74K
Veer Bhavnagri
15 Mar 2021
General Counsel
Sold after exercise
400
$38.15
$15.26K
Veer Bhavnagri
15 Mar 2021
General Counsel
Sold after exercise
9,600
$37.79
$362.81K
Veer Bhavnagri
15 Mar 2021
General Counsel
Sold after exercise
6,623
$38.16
$252.73K
Alison Moore
13 Oct 2020
Chief Technical Officer
Sold after exercise
11,031
$42.00
$463.30K
Alison Moore
12 Oct 2020
Chief Technical Officer
Sold after exercise
24,233
$42.00
$1.02M
Alison Moore
9 Oct 2020
Chief Technical Officer
Sold after exercise
39,509
$41.00
$1.62M
Alison Moore
8 Oct 2020
Chief Technical Officer
Sold after exercise
5,065
$41.00
$207.67K
Veer Bhavnagri
6 Oct 2020
General Counsel
Sold after exercise
10,000
$40.00
$400.00K
Alison Moore
6 Oct 2020
Chief Technical Officer
Sold after exercise
44,574
$40.00
$1.78M
Veer Bhavnagri
1 Oct 2020
General Counsel
Sold after exercise
800
$37.73
$30.18K
Veer Bhavnagri
1 Oct 2020
General Counsel
Sold after exercise
7,985
$37.03
$295.66K
Veer Bhavnagri
1 Oct 2020
General Counsel
Sold after exercise
16,215
$36.21
$587.07K
Veer Bhavnagri
1 Sep 2020
General Counsel
Sold after exercise
400
$35.89
$14.36K
Veer Bhavnagri
1 Sep 2020
General Counsel
Sold after exercise
24,600
$35.35
$869.61K
Veer Bhavnagri
3 Aug 2020
General Counsel
Sold after exercise
16,450
$37.29
$613.40K
Veer Bhavnagri
3 Aug 2020
General Counsel
Sold after exercise
15,103
$36.46
$550.72K
Alison Moore
18 Sep 2019
Chief Technical Officer
Sold after exercise
21,067
$32.13
$676.87K
Alison Moore
17 Sep 2019
Chief Technical Officer
Sold after exercise
22,503
$32.11
$722.56K
Alison Moore
16 Sep 2019
Chief Technical Officer
Sold after exercise
5,257
$32.00
$168.23K
Alison Moore
30 Jul 2019
Chief Technical Officer
Sold after exercise
11,819
$29.85
$352.74K
Alison Moore
29 Jul 2019
Chief Technical Officer
Sold after exercise
23,815
$29.39
$699.87K
Alison Moore
26 Jul 2019
Chief Technical Officer
Sold after exercise
13,193
$29.18
$384.99K
Alison Moore
3 Jun 2019
Chief Technical Officer
Sold after exercise
1,623
$27.31
$44.32K
Alison Moore
3 Jun 2019
Chief Technical Officer
Sold after exercise
47,205
$26.74
$1.26M
Show all 153 transactions →

What was left out

Form 4 filings counted 244
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 32
Sales at will 98
Transactions with no price 0
Shares from compensation/vesting 102,298,948
Sales filed before the plan box existed 70
History held since 17 Oct 2018